These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 29984488)

  • 1. Bayesian basket trial design with exchangeability monitoring.
    Hobbs BP; Landin R
    Stat Med; 2018 Nov; 37(25):3557-3572. PubMed ID: 29984488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bayesian basket trial design with false-discovery rate control.
    Zabor EC; Kane MJ; Roychoudhury S; Nie L; Hobbs BP
    Clin Trials; 2022 Jun; 19(3):297-306. PubMed ID: 35128970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bayesian hierarchical models for adaptive basket trial designs.
    Chen C; Hsiao CF
    Pharm Stat; 2023; 22(3):531-546. PubMed ID: 36625301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bayesian and frequentist approaches to sequential monitoring for futility in oncology basket trials: A comparison of Simon's two-stage design and Bayesian predictive probability monitoring with information sharing across baskets.
    Kaizer A; Zabor E; Nie L; Hobbs B
    PLoS One; 2022; 17(8):e0272367. PubMed ID: 35917296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Bayesian basket trial design using a calibrated Bayesian hierarchical model.
    Chu Y; Yuan Y
    Clin Trials; 2018 Apr; 15(2):149-158. PubMed ID: 29499621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variance prior specification for a basket trial design using Bayesian hierarchical modeling.
    Cunanan KM; Iasonos A; Shen R; Gönen M
    Clin Trials; 2019 Apr; 16(2):142-153. PubMed ID: 30526008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statistical challenges posed by uncontrolled master protocols: sensitivity analysis of the vemurafenib study.
    Hobbs BP; Kane MJ; Hong DS; Landin R
    Ann Oncol; 2018 Dec; 29(12):2296-2301. PubMed ID: 30335125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of Bayesian information borrowing methods in basket trials and a novel proposal of modified exchangeability-nonexchangeability method.
    Daniells L; Mozgunov P; Bedding A; Jaki T
    Stat Med; 2023 Oct; 42(24):4392-4417. PubMed ID: 37614070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Bayesian basket trial design that borrows information across strata based on the similarity between the posterior distributions of the response probability.
    Fujikawa K; Teramukai S; Yokota I; Daimon T
    Biom J; 2020 Mar; 62(2):330-338. PubMed ID: 31608505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Constrained hierarchical Bayesian model for latent subgroups in basket trials with two classifiers.
    Takeda K; Liu S; Rong A
    Stat Med; 2022 Jan; 41(2):298-309. PubMed ID: 34697822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monotonicity conditions for avoiding counterintuitive decisions in basket trials.
    Baumann L; Krisam J; Kieser M
    Biom J; 2022 Jun; 64(5):934-947. PubMed ID: 35692061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bayesian borrowing for basket trials with longitudinal outcomes.
    Whitehead LE; Sailer O; Witham MD; Wason JMS
    Stat Med; 2023 Jul; 42(16):2819-2840. PubMed ID: 37120858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Bayesian basket trial design accounting for uncertainties of homogeneity and heterogeneity of treatment effect among subpopulations.
    Asano J; Hirakawa A
    Pharm Stat; 2020 Nov; 19(6):975-1000. PubMed ID: 32779393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An efficient basket trial design.
    Cunanan KM; Iasonos A; Shen R; Begg CB; Gönen M
    Stat Med; 2017 May; 36(10):1568-1579. PubMed ID: 28098411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. rBMA: A robust Bayesian Model Averaging Method for phase II basket trials based on informative mixture priors.
    Wang X; Wei W
    Contemp Clin Trials; 2024 May; 140():107505. PubMed ID: 38521384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An extension of Bayesian predictive sample size selection designs for monitoring efficacy and safety.
    Teramukai S; Daimon T; Zohar S
    Stat Med; 2015 Sep; 34(22):3029-39. PubMed ID: 26038148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A nonparametric Bayesian basket trial design.
    Xu Y; Müller P; Tsimberidou AM; Berry D
    Biom J; 2019 Sep; 61(5):1160-1174. PubMed ID: 29808479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimal two-stage designs for exploratory basket trials.
    Zhou H; Liu F; Wu C; Rubin EH; Giranda VL; Chen C
    Contemp Clin Trials; 2019 Oct; 85():105807. PubMed ID: 31260789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Bayesian Hybrid Adaptive Randomisation Design for Clinical Trials with Survival Outcomes.
    Moatti M; Chevret S; Zohar S; Rosenberger WF
    Methods Inf Med; 2016; 55(1):4-13. PubMed ID: 26404511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New clinical trial designs in the era of precision medicine: An overview of definitions, strengths, weaknesses, and current use in oncology.
    Janiaud P; Serghiou S; Ioannidis JPA
    Cancer Treat Rev; 2019 Feb; 73():20-30. PubMed ID: 30572165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.